Pheochromocytoma and Paraganglioma

Displaying 1 - 6 of 6CSV
Zhang, C., Zhao, N., Khan, R., Hung, M., Zhang, C., Wang, S., Wang, T. J. C., & Lin, C. (2024). The prognostic significance of androgen receptor expression in gliomas. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-72284-4
Publication Date
Lin, A. L., Rudneva, V. A., Richards, A. L., Zhang, Y., Woo, H. J., Cohen, M., Tisnado, J., Majd, N., Wardlaw, S. L., Page-Wilson, G., Sengupta, S., Chow, F., Goichot, B., Ozer, B. H., Dietrich, J., Nachtigall, L., Desai, A., Alano, T., Ogilive, S., … Tabar, V. (2024). Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors. Acta Neuropathologica, 147(1). https://doi.org/10.1007/s00401-024-02736-8
Publication Date
McLennan, G., Quencer, K., Dolmatch, B., Kennedy, R., McClure, T., Vingan, H., Arslan, B., Werder, G., Krishnasamy, V., Le, T., Meisinger, Q., Muller, R., Field, D., Haddad, M., Kumari, D., Kulkarni, S., Nguyen, Q., Achakzai, B., Sharma, P., … Penninga Brown, E. (2024). Abstract No. 292 Distribution of Interventional Radiology Expertise with Management of Primary Aldosteronism–Related Hypertension. Journal of Vascular and Interventional Radiology, 35(3), S129. https://doi.org/10.1016/j.jvir.2023.12.333
Publication Date
Donovan, L., Joanta-Gomez, A., Furnari, J., Mouton, B., & Lassman, A. (2022). QOL-01. RISK FACTORS FOR AND CONSEQUENCES OF PROLONGED DEXAMETHASONE USE IN PATIENTS WITH GLIOBLASTOMA (GBM). Neuro-Oncology, 24(Supplement_7), vii240–vii240. https://doi.org/10.1093/neuonc/noac209.929
Publication Date
Kumthekar, P., Grimm, S. A., Aleman, R. T., Chamberlain, M. C., Schiff, D., Wen, P. Y., Iwamoto, F. M., Gursel, D. B., Reardon, D. A., Purow, B., Kocherginski, M., Helenowski, I., & Raizer, J. J. (2022). A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma. Neuro-Oncology Advances, 4(1). https://doi.org/10.1093/noajnl/vdac123
Publication Date